4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Volume 36 Issue 5
Sep.  2022
Turn off MathJax
Article Contents
Abstract
References
Related Articles
Xiaolong Zheng, Wei Wang. Astrocyte transplantation for repairing the injured spinal cord[J]. The Journal of Biomedical Research, 2022, 36(5): 312-320. DOI: 10.7555/JBR.36.20220012
Citation: Xiaolong Zheng, Wei Wang. Astrocyte transplantation for repairing the injured spinal cord[J]. The Journal of Biomedical Research, 2022, 36(5): 312-320. DOI: 10.7555/JBR.36.20220012
shu

Astrocyte transplantation for repairing the injured spinal cord

  • 1.

    Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China

  • 2.

    Key Laboratory of Neurological Diseases of Chinese Ministry of Education, the School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China

More Information
  • Corresponding author:

    Wei Wang, Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei 430030, China. Tel: +86-27-83663657, E-mail: wwang@vip.126.com

  • Received Date: January 10, 2022
  • Revised Date: April 12, 2022
  • Accepted Date: May 12, 2022
  • Available Online: June 27, 2022
    Graphical Abstract
    • Abstract
  • Spinal cord injury (SCI) leads to permanent deficits in neural function without effective therapies, which places a substantial burden on families and society. Astrocytes, the major glia supporting the normal function of neurons in the spinal cord, become active and form glial scars after SCI, which has long been regarded as a barrier for axon regeneration. However, recent progress has indicated the beneficial role of astrocytes in spinal repair. During the past three decades, astrocyte transplantation for SCI treatment has gained increasing attention. In this review, we first summarize the progress of using rodent astrocytes as the primary step for spinal repair. Rodent astrocytes can survive well, migrate extensively, and mature in spinal injury; they can also inhibit host reactive glial scar formation, stimulate host axon regeneration, and promote motor, sensory, respiratory, and autonomic functional recovery. Then, we review the progress in spinal repair by using human astrocytes of various origins, including the fetal brain, fetal spinal cord, and pluripotent stem cells. Finally, we introduce some key questions that merit further research in the future, including rapid generation of large amounts of human astrocytes with high purity, identification of the right origins of astrocytes to maximize neural function improvement while minimizing side effects, testing human astrocyte transplantation in chronic SCI, and verification of the long-term efficacy and safety in large animal models.
    • FullText(HTML)

  • CLC number: R651.2, Document code: A

    The authors reported no conflict of interests.

    • References (78)
  • [1]
    Ahuja CS, Wilson JR, Nori S, et al. Traumatic spinal cord injury[J]. Nat Rev Dis Primers, 2017, 3: 17018. doi: 10.1038/nrdp.2017.18
    [2]
    GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2019, 18(1): 56–87. doi: 10.1016/S1474-4422(18)30415-0
    [3]
    O'Shea TM, Burda JE, Sofroniew MV. Cell biology of spinal cord injury and repair[J]. J Clin Investigation, 2017, 127(9): 3259–3270. doi: 10.1172/JCI90608
    [4]
    Assinck P, Duncan GJ, Hilton BJ, et al. Cell transplantation therapy for spinal cord injury[J]. Nat Neurosci, 2017, 20(5): 637–647. doi: 10.1038/nn.4541
    [5]
    Vismara I, Papa S, Rossi F, et al. Current options for cell therapy in spinal cord injury[J]. Trends Mol Med, 2017, 23(9): 831–849. doi: 10.1016/j.molmed.2017.07.005
    [6]
    Fischer I, Dulin JN, Lane MA. Transplanting neural progenitor cells to restore connectivity after spinal cord injury[J]. Nat Rev Neurosci, 2020, 21(7): 366–383. doi: 10.1038/s41583-020-0314-2
    [7]
    Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury[J]. J Neurosci, 2005, 25(19): 4694–4705. doi: 10.1523/JNEUROSCI.0311-05.2005
    [8]
    Kawabata S, Takano M, Numasawa-Kuroiwa Y, et al. Grafted human iPS cell-derived oligodendrocyte precursor cells contribute to robust remyelination of demyelinated axons after spinal cord injury[J]. Stem Cell Reports, 2016, 6(1): 1–8. doi: 10.1016/j.stemcr.2015.11.013
    [9]
    Nagoshi N, Khazaei M, Ahlfors JE, et al. Human spinal oligodendrogenic neural progenitor cells promote functional recovery after spinal cord injury by axonal remyelination and tissue sparing[J]. Stem Cells Transl Med, 2018, 7(11): 806–818. doi: 10.1002/sctm.17-0269
    [10]
    Verkhratsky A, Nedergaard M. Physiology of astroglia[J]. Physiol Rev, 2018, 98(1): 239–389. doi: 10.1152/physrev.00042.2016
    [11]
    Silver J, Miller JH. Regeneration beyond the glial scar[J]. Nat Rev Neurosci, 2004, 5(2): 146–156. doi: 10.1038/nrn1326
    [12]
    Faulkner JR, Herrmann JE, Woo MJ, et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury[J]. J Neurosci, 2004, 24(9): 2143–2155. doi: 10.1523/JNEUROSCI.3547-03.2004
    [13]
    Gu Y, Cheng X, Huang X, et al. Conditional ablation of reactive astrocytes to dissect their roles in spinal cord injury and repair[J]. Brain Behav Immun, 2019, 80: 394–405. doi: 10.1016/j.bbi.2019.04.016
    [14]
    Anderson MA, Burda JE, Ren Y, et al. Astrocyte scar formation aids central nervous system axon regeneration[J]. Nature, 2016, 532(7598): 195–200. doi: 10.1038/nature17623
    [15]
    Song JJ, Oh SM, Kwon OC, et al. Cografting astrocytes improves cell therapeutic outcomes in a Parkinson's disease model[J]. J Clin Invest, 2018, 128(1): 463–482. doi: 10.1172/JCI93924
    [16]
    Hedegaard A, Monzón-Sandoval J, Newey SE, et al. Pro-maturational effects of human iPSC-derived cortical astrocytes upon iPSC-derived cortical neurons[J]. Stem Cell Reports, 2020, 15(1): 38–51. doi: 10.1016/j.stemcr.2020.05.003
    [17]
    Han X, Chen M, Wang F, et al. Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice[J]. Cell Stem Cell, 2013, 12(3): 342–353. doi: 10.1016/j.stem.2012.12.015
    [18]
    Jiang P, Chen C, Liu X, et al. Human iPSC-derived immature astroglia promote oligodendrogenesis by increasing TIMP-1 secretion[J]. Cell Reports, 2016, 15(6): 1303–1315. doi: 10.1016/j.celrep.2016.04.011
    [19]
    Noble M, Davies JE, Mayer-Pröschel M, et al. Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury[J]. Neurotherapeutics, 2011, 8(4): 677–693. doi: 10.1007/s13311-011-0071-z
    [20]
    Chu T, Zhou H, Li F, et al. Astrocyte transplantation for spinal cord injury: current status and perspective[J]. Brain Res Bull, 2014, 107: 18–30. doi: 10.1016/j.brainresbull.2014.05.003
    [21]
    Falnikar A, Li K, Lepore AC. Therapeutically targeting astrocytes with stem and progenitor cell transplantation following traumatic spinal cord injury[J]. Brain Res, 2015, 1619: 91–103. doi: 10.1016/j.brainres.2014.09.037
    [22]
    Nicaise C, Mitrecic D, Falnikar A, et al. Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury[J]. World J Stem Cells, 2015, 7(2): 380–398. doi: 10.4252/wjsc.v7.i2.380
    [23]
    Chen C, Chan A, Wen H, et al. Stem and progenitor cell-derived astroglia therapies for neurological diseases[J]. Trends Mol Med, 2015, 21(11): 715–729. doi: 10.1016/j.molmed.2015.09.003
    [24]
    Martins-Macedo J, Lepore AC, Domingues HS, et al. Glial restricted precursor cells in central nervous system disorders: current applications and future perspectives[J]. Glia, 2021, 69(3): 513–531. doi: 10.1002/glia.23922
    [25]
    Han SSW, Liu Y, Tyler-Polsz C, et al. Transplantation of glial-restricted precursor cells into the adult spinal cord: survival, glial-specific differentiation, and preferential migration in white matter[J]. Glia, 2004, 45(1): 1–16. doi: 10.1002/glia.10282
    [26]
    Lepore AC, Fischer I. Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord[J]. Exp Neurol, 2005, 194(1): 230–242. doi: 10.1016/j.expneurol.2005.02.020
    [27]
    Haas C, Neuhuber B, Yamagami T, et al. Phenotypic analysis of astrocytes derived from glial restricted precursors and their impact on axon regeneration[J]. Exp Neurol, 2012, 233(2): 717–732. doi: 10.1016/j.expneurol.2011.11.002
    [28]
    Hill CE, Proschel C, Noble M, et al. Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration[J]. Exp Neurol, 2004, 190(2): 289–310. doi: 10.1016/j.expneurol.2004.05.043
    [29]
    Wang JJ, Chuah MI, Yew DTW, et al. Effects of astrocyte implantation into the hemisected adult rat spinal cord[J]. Neuroscience, 1995, 65(4): 973–981. doi: 10.1016/0306-4522(94)00519-B
    [30]
    Pencalet P, Serguera C, Corti O, et al. Integration of genetically modified adult astrocytes into the lesioned rat spinal cord[J]. J Neurosci Res, 2006, 83(1): 61–67. doi: 10.1002/jnr.20697
    [31]
    Kliot M, Smith GM, Siegal JD, et al. Astrocyte-polymer implants promote regeneration of dorsal root fibers into the adult mammalian spinal cord[J]. Exp Neurol, 1990, 109(1): 57–69. doi: 10.1016/S0014-4886(05)80008-1
    [32]
    Kadoya K, Lu P, Nguyen K, et al. Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration[J]. Nat Med, 2016, 22(5): 479–487. doi: 10.1038/nm.4066
    [33]
    Olby NJ, Blakemore WF. Reconstruction of the glial environment of a photochemically induced lesion in the rat spinal cord by transplantation of mixed glial cells[J]. J Neurocytol, 1996, 25(1): 481–498. doi: 10.1007/BF02284817
    [34]
    Schackel T, Kumar P, Günther M, et al. Peptides and astroglia improve the regenerative capacity of alginate gels in the injured spinal cord[J]. Tissue Eng Part A, 2019, 25(7–8): 522–537. doi: 10.1089/ten.tea.2018.0082
    [35]
    Anderson KD. Targeting recovery: priorities of the spinal cord-injured population[J]. J Neurotrauma, 2004, 21(10): 1371–1383. doi: 10.1089/neu.2004.21.1371
    [36]
    Simpson LA, Eng JJ, Hsieh JTC, et al. The health and life priorities of individuals with spinal cord injury: a systematic review[J]. J Neurotrauma, 2012, 29(8): 1548–1555. doi: 10.1089/neu.2011.2226
    [37]
    Bernstein JJ, Goldberg WJ. Grafted fetal astrocyte migration can prevent host neuronal atrophy: comparison of astrocytes from cultures and whole piece donors[J]. Restor Neurol Neurosci, 1991, 2(4-6): 261–270. doi: 10.3233/RNN-1991-245615
    [38]
    Davies JE, Huang C, Proschel C, et al. Astrocytes derived from glial-restricted precursors promote spinal cord repair[J]. J Biol, 2006, 5(3): 7. doi: 10.1186/jbiol35
    [39]
    Davies JE, Pröschel C, Zhang N, et al. Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury[J]. J Biol, 2008, 7(7): 24. doi: 10.1186/jbiol85
    [40]
    Fan C, Zheng Y, Cheng X, et al. Transplantation of D15A-expressing glial-restricted-precursor-derived astrocytes improves anatomical and locomotor recovery after spinal cord injury[J]. Int J Biol Sci, 2013, 9(1): 78–93. doi: 10.7150/ijbs.5626
    [41]
    Wu L, Li J, Chen L, et al. Combined transplantation of GDAsBMP and hr-decorin in spinal cord contusion repair[J]. Neural Regen Res, 2013, 8(24): 2236–2248. doi: 10.3969/j.issn.1673-5374.2013.24.003
    [42]
    Mitsui T, Shumsky JS, Lepore AC, et al. Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry[J]. J Neurosci, 2005, 25(42): 9624–9636. doi: 10.1523/JNEUROSCI.2175-05.2005
    [43]
    Joosten EAJ, Veldhuis WB, Hamers FPT. Collagen containing neonatal astrocytes stimulates regrowth of injured fibers and promotes modest locomotor recovery after spinal cord injury[J]. J Neurosci Res, 2004, 77(1): 127–142. doi: 10.1002/jnr.20088
    [44]
    Xu J, Bernreuther C, Cui Y, et al. Transplanted L1 expressing radial glia and astrocytes enhance recovery after spinal cord injury[J]. J Neurotrauma, 2011, 28(9): 1921–1937. doi: 10.1089/neu.2011.1783
    [45]
    Hofstetter CP, Holmström NAV, Lilja JA, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome[J]. Nat Neurosci, 2005, 8(3): 346–353. doi: 10.1038/nn1405
    [46]
    Macias MY, Syring MB, Pizzi MA, et al. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury[J]. Exp Neurol, 2006, 201(2): 335–348. doi: 10.1016/j.expneurol.2006.04.035
    [47]
    Hayashi K, Hashimoto M, Koda M, et al. Increase of sensitivity to mechanical stimulus after transplantation of murine induced pluripotent stem cell-derived astrocytes in a rat spinal cord injury model[J]. J Neurosurg Spine, 2011, 15(6): 582–593. doi: 10.3171/2011.7.SPINE10775
    [48]
    Goulão M, Ghosh B, Urban MW, et al. Astrocyte progenitor transplantation promotes regeneration of bulbospinal respiratory axons, recovery of diaphragm function, and a reduced macrophage response following cervical spinal cord injury[J]. Glia, 2019, 67(3): 452–466. doi: 10.1002/glia.23555
    [49]
    Li K, Javed E, Hala TJ, et al. Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI[J]. Mol Ther, 2015, 23(3): 533–548. doi: 10.1038/mt.2014.236
    [50]
    Jin Y, Shumsky JS, Fischer I. Axonal regeneration of different tracts following transplants of human glial restricted progenitors into the injured spinal cord in rats[J]. Brain Res, 2018, 1686: 101–112. doi: 10.1016/j.brainres.2018.01.030
    [51]
    Haas C, Fischer I. Human astrocytes derived from glial restricted progenitors support regeneration of the injured spinal cord[J]. J Neurotrauma, 2013, 30(12): 1035–1052. doi: 10.1089/neu.2013.2915
    [52]
    Jin Y, Neuhuber B, Singh A, et al. Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury[J]. J Neurotrauma, 2011, 28(4): 579–594. doi: 10.1089/neu.2010.1626
    [53]
    Davies SJA, Shih CH, Noble M, et al. Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury[J]. PLoS One, 2011, 6(3): e17328. doi: 10.1371/journal.pone.0017328
    [54]
    Shamblott MJ, Axelman J, Wang S, et al. Derivation of pluripotent stem cells from cultured human primordial germ cells[J]. Proc Natl Acad Sci U S A, 1998, 95(23): 13726–13731. doi: 10.1073/pnas.95.23.13726
    [55]
    Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts[J]. Science, 1998, 282(5391): 1145–1147. doi: 10.1126/science.282.5391.1145
    [56]
    Reubinoff BE, Pera MF, Fong CY, et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro[J]. Nat Biotechnol, 2000, 18(4): 399–404. doi: 10.1038/74447
    [57]
    Reubinoff BE, Itsykson P, Turetsky T, et al. Neural progenitors from human embryonic stem cells[J]. Nat Biotechnol, 2001, 19(12): 1134–1140. doi: 10.1038/nbt1201-1134
    [58]
    Zhang S, Wernig M, Duncan ID, et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells[J]. Nat Biotechnol, 2001, 19(12): 1129–1133. doi: 10.1038/nbt1201-1129
    [59]
    Chen H, Qian K, Chen W, et al. Human-derived neural progenitors functionally replace astrocytes in adult mice[J]. J Clin Invest, 2015, 125(3): 1033–1042. doi: 10.1172/JCI69097
    [60]
    Lu P, Ceto S, Wang Y, et al. Prolonged human neural stem cell maturation supports recovery in injured rodent CNS[J]. J Clin Invest, 2017, 127(9): 3287–3299. doi: 10.1172/JCI92955
    [61]
    Lien BV, Tuszynski MH, Lu P. Astrocytes migrate from human neural stem cell grafts and functionally integrate into the injured rat spinal cord[J]. Exp Neurol, 2019, 314: 46–57. doi: 10.1016/j.expneurol.2019.01.006
    [62]
    Roybon L, Lamas NJ, Garcia-Diaz A, et al. Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes[J]. Cell Reports, 2013, 4(5): 1035–1048. doi: 10.1016/j.celrep.2013.06.021
    [63]
    Haidet-Phillips AM, Roybon L, Gross SK, et al. Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment[J]. Stem Cells Transl Med, 2014, 3(5): 575–585. doi: 10.5966/sctm.2013-0153
    [64]
    Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4): 663–676. doi: 10.1016/j.cell.2006.07.024
    [65]
    Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors[J]. Cell, 2007, 131(5): 861–872. doi: 10.1016/j.cell.2007.11.019
    [66]
    Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells[J]. Science, 2007, 318(5858): 1917–1920. doi: 10.1126/science.1151526
    [67]
    Li K, Javed E, Scura D, et al. Human iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury[J]. Exp Neurol, 2015, 271: 479–492. doi: 10.1016/j.expneurol.2015.07.020
    [68]
    Qian K, Huang H, Peterson A, et al. Sporadic ALS astrocytes induce neuronal degeneration in vivo[J]. Stem Cell Reports, 2017, 8(4): 843–855. doi: 10.1016/j.stemcr.2017.03.003
    [69]
    Krencik R, Weick JP, Liu Y, et al. Specification of transplantable astroglial subtypes from human pluripotent stem cells[J]. Nat Biotechnol, 2011, 29(6): 528–534. doi: 10.1038/nbt.1877
    [70]
    Krencik R, Zhang S. Directed differentiation of functional astroglial subtypes from human pluripotent stem cells[J]. Nat Protoc, 2011, 6(11): 1710–1717. doi: 10.1038/nprot.2011.405
    [71]
    Li X, Tao Y, Bradley R, et al. Fast generation of functional subtype astrocytes from human pluripotent stem cells[J]. Stem Cell Reports, 2018, 11(4): 998–1008. doi: 10.1016/j.stemcr.2018.08.019
    [72]
    Tchieu J, Calder EL, Guttikonda SR, et al. NFIA is a gliogenic switch enabling rapid derivation of functional human astrocytes from pluripotent stem cells[J]. Nat Biotechnol, 2019, 37(3): 267–275. doi: 10.1038/s41587-019-0035-0
    [73]
    Bradley RA, Shireman J, McFalls C, et al. Regionally specified human pluripotent stem cell-derived astrocytes exhibit different molecular signatures and functional properties[J]. Development, 2019, 146(13): dev170910. doi: 10.1242/dev.170910
    [74]
    Kumamaru H, Kadoya K, Adler AF, et al. Generation and post-injury integration of human spinal cord neural stem cells[J]. Nat Methods, 2018, 15(9): 723–731. doi: 10.1038/s41592-018-0074-3
    [75]
    van Middendorp JJ, Allison H, Cowan K, et al. Top ten research priorities for spinal cord injury[J]. Lancet Neurol, 2014, 13(12): 1167. doi: 10.1016/S1474-4422(14)70253-4
    [76]
    Courtine G, Bunge MB, Fawcett JW, et al. Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?[J]. Nat Med, 2007, 13(5): 561–566. doi: 10.1038/nm1595
    [77]
    Kwon BK, Streijger F, Hill CE, et al. Large animal and primate models of spinal cord injury for the testing of novel therapies[J]. Exp Neurol, 2015, 269: 154–168. doi: 10.1016/j.expneurol.2015.04.008
    [78]
    Kwon BK, Soril LJJ, Bacon M, et al. Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - How much is enough?[J]. Exp Neurol, 2013, 248: 30–44. doi: 10.1016/j.expneurol.2013.05.012
    • Related Articles

  • Related Articles

    [1]Siying Wang, Saiya Wang, Wenhan Cai, Jie Wang, Jianan Huang, Qing Yang, Hui Bai, Bin Jiang, Jingjing Ben, Hanwen Zhang, Xudong Zhu, Xiaoyu Li, Qi Chen. Macrophage scavenger receptor A1 promotes skeletal muscle regeneration after hindlimb ischemia[J]. The Journal of Biomedical Research, 2025, 39(1): 23-35. DOI: 10.7555/JBR.38.20240117
    [2]Qian Sun, Yusi Hu, Saiyue Deng, Yanyu Xiong, Zhili Huang. A visualization pipeline for in vivo two-photon volumetric astrocytic calcium imaging[J]. The Journal of Biomedical Research, 2022, 36(5): 358-367. DOI: 10.7555/JBR.36.20220099
    [3]Rampes Sanketh, Ma Daqing. Hepatic ischemia-reperfusion injury in liver transplant setting: mechanisms and protective strategies[J]. The Journal of Biomedical Research, 2019, 33(4): 221-234. DOI: 10.7555/JBR.32.20180087
    [4]Maglione Michele, Salvador Enrico, Ruaro Maria E., Melato Mauro, Tromba Giuliana, Angerame Daniele, Bevilacqua Lorenzo. Bone regeneration with adipose derived stem cells in a rabbit model[J]. The Journal of Biomedical Research, 2019, 33(1): 38-45. DOI: 10.7555/JBR.32.20160066
    [5]Kaibo Lin, Shikun Zhang, Jieli Chen, Ding Yang, Mengyi Zhu, Eugene Yujun Xu. Generation and functional characterization of a conditional Pumilio2 null allele[J]. The Journal of Biomedical Research, 2018, 32(6): 434-441. DOI: 10.7555/JBR.32.20170117
    [6]Fengzhen Wang, Mingwan Zhang, Dongsheng Zhang, Yuan Huang, Li Chen, Sunmin Jiang, Kun Shi, Rui Li. Preparation, optimization, and characterization of chitosancoated solid lipid nanoparticles for ocular drug delivery[J]. The Journal of Biomedical Research, 2018, 32(6): 411-423. DOI: 10.7555/JBR.32.20160170
    [7]Christopher J. Danford, Zemin Yao, Z. Gordon Jiang. Non-alcoholic fatty liver disease: a narrative review of genetics[J]. The Journal of Biomedical Research, 2018, 32(6): 389-400. DOI: 10.7555/JBR.32.20180045
    [8]David K.C. Cooper, Hidetaka Hara, Mohamed Ezzelarab, Rita Bottino, Massimo Trucco, Carol Phelps, David Ayares, Yifan Dai. The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation[J]. The Journal of Biomedical Research, 2013, 27(4): 249-253. DOI: 10.7555/JBR.27.20130063
    [9]Wujun?Xue, Yong?Song, Puxun?Tian, Xiaoming?Ding, Xiaoming?Pan, Hang?Yan, Jun?Hou, Xinshun?Feng, Heli?Xiang, Xiaohui?Tian. The?effects?of?diltiazem?in?renal?transplantation?patients?treated?with?cyclosporine?A[J]. The Journal of Biomedical Research, 2010, 24(4): 317-323. DOI: 10.1016/S1674-8301(10)60044-9
    [10]Zhigang He. Intrinsic control of axon regeneration[J]. The Journal of Biomedical Research, 2010, 24(1): 2-5.

Catalog

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1570) PDF downloads (228) Cited by()
    Related

    ©2023 by the Editorial Department of the Journals of Nanjing Medical University. All rights reserved.   苏ICP备05071376号-5

    Supported by: Beijing Renhe Information Technology Co., Ltd. E-mail: info@rhhz.net  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return